H&R GmbH & Co. KGaA (ETR:2HRA)

Germany · Delayed Price · Currency is EUR

4.840

0.00 (0.00%)

Jun 17, 2026, 5:35 PM CET

-2.62% (1Y)

Market Cap	180.15M -3.0%
Revenue (ttm)	1.21B -11.0%
Net Income	-36.80M
EPS	-0.98
Shares Out	37.22M
PE Ratio	n/a
Forward PE	30.79
Dividend	0.10 (2.07%)
Ex-Dividend Date	May 28, 2025

Volume	115
Open	4.780
Previous Close	4.840
Day's Range	4.780 - 4.840
52-Week Range	3.910 - 5.040
Beta	0.36
Analysts	Sell
Price Target	4.30 (-11.16%)
Earnings Date	Aug 14, 2026

About H&R GmbH & Co. KGaA

H&R GmbH & Co. KGaA engages in the production and sale of chemical-pharmaceutical raw materials and injection molded precision plastic parts worldwide. It operates through three segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment offers paraffins, white oils, plasticizers, base oils, lubricants, and other crude-oil based specialty products, as well as bitumen, feedstocks, and bunker fuel. The ChemPharm Sales segment provides paraffins, plasticizers, wax emulsions, and other crude-oil based specialty produ... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 1919

Employees 1,692

Stock Exchange Deutsche Börse Xetra

Ticker Symbol 2HRA

Full Company Profile

Financial Performance

Financial Statements

Analyst Summary

According to 2 analysts, the average rating for 2HRA stock is "Sell." The 12-month stock price target is €4.30, which is a decrease of -11.16% from the latest price.

Price Target

€4.30

(-11.16% downside)

Analyst Consensus: Sell

Stock Forecasts